Role of TIPS in Improving Survival of Patients with Decompensated Liver Disease by Sundeep J. Punamiya, Deepak N. Amarapurkar

“…Liver cirrhosis is associated with higher morbidity and reduced survival with appearance of portal hypertension and resultant decompensation. …”
Get full text

Liver lobes and cirrhosis: Diagnostic insights from lobar ratios by Kriti Pandey, Debabrata Dash, Raj Kumar Koiri

Subjects: “…Liver cirrhosis…”
Get full text

Induction of MASH in three-dimensional bioprinted human liver tissue. by Vaidehi Joshi, Dwayne Carter, Alice E Chen, Keith Murphy, J William Higgins, Mediha Gurel, Daisy Chilin Fuentes, Sara Brin Rosenthal, Kathleen M Fisch, Tatiana Kisseleva, David A Brenner

“…Metabolic dysfunction-associated steatohepatitis (MASH), formerly known as nonalcoholic steatohepatitis (MASH), is a major risk factor for cirrhosis and hepatocellular carcinoma (HCC) and a leading cause of liver transplantation. MASH is caused by an accumulation of toxic fat molecules in the hepatocyte which leads to inflammation and fibrosis. …”
Get full text

Timing of Hepatic Artery Reperfusion and Biliary Strictures in Liver Transplantation by Ganesh Gunasekaran, Jyoti Sharma, Leandro C. Mosna, Roxana Bodin, David C. Wolf

Get full text

Modern treatment methods of patients with liver metastases of colorectal cancer by Ye. N. Grebenkin, V. D. Chhikvadze, U. S. Stanoyevich, Ye. I. Dekhissi

Subjects: Get full text

Azole-Induced Myositis after Combined Lung-Liver Transplantation by Sofie Happaerts, Michiel Wieërs, Ward Vander Mijnsbrugge, Laurent Godinas, Dirk Van Raemdonck, Laurens J. Ceulemans, Robin Vos, Geert M. Verleden

“…Our patient was a 38-year-old man who received a single sequential lung transplantation and liver transplantation because of end-stage cystic fibrosis. …”
Get full text

Endothelial Dysfunction Correlates with Liver Fibrosis in Chronic HCV Infection by Michele Barone, Maria Teresa Viggiani, Annabianca Amoruso, Serafina Schiraldi, Annapaola Zito, Fiorella Devito, Francesca Cortese, Michele Gesualdo, Natale Brunetti, Alfredo Di Leo, Pietro Scicchitano, Marco Matteo Ciccone

“…Hepatitis C virus (HCV) infection can exert proatherogenic activities due to its direct action on vessel walls and/or via the chronic inflammatory process involving the liver. Aims. To clarify the role of HCV in atherosclerosis development in monoinfected HCV patients at different degrees of liver fibrosis and with no risk factors for coronary artery disease. …”
Get full text

Drug Therapy for Non-Alcoholic Steatohepatitis-Induced Liver Fibrosis by D. V. Garbuzenko

Subjects: Get full text

The role of the pulmonary function laboratory in the management of gastrointestinal and liver diseases by José Alberto Neder, Denis E O’Donnell, Danilo C Berton

Get full text

Vascular malformations of the lungs and the liver at patient with hereditary hemorrhagic teleangiectasia by M. S. Zharkova, A. V. Lapshin, Ye. N. German, M. V. Mayevskaya, I. A. Sokolina, V. T. Ivashkin

Subjects: “…diffuse arteriovenous malformations of the lungs and the liver…”
Get full text

Lessons Learned from Liver Transplantation with the Canadian First Nations by Aldo J Montano-Loza, Robert P Myers, Andrew L Mason

Get full text

Noninvasive Assessment of Fibrosis in Patients with Nonalcoholic Fatty Liver Disease by Elena Buzzetti, Rosa Lombardi, Laura De Luca, Emmanuel A. Tsochatzis

“…Nonalcoholic fatty liver disease (NAFLD) is prevalent in 20–25% of the general population and is associated with metabolic risk factors such as obesity, diabetes mellitus, and dyslipidemia. …”
Get full text

Organoids and spheroids: advanced in vitro models for liver cancer research by Mirella Pastore, Alessia Giachi, Elena Spínola-Lasso, Fabio Marra, Chiara Raggi

Subjects: Get full text

Diacylglycerol kinase alpha regulates post-hepatectomy liver regeneration by Hiroki Nakamoto, Shunsuke Shichi, Chisato Shirakawa, Takuto Suzuki, Hidemitsu Kitamura, Akinobu Taketomi

Subjects: Get full text

Preclinical advance in nanoliposome-mediated photothermal therapy in liver cancer by Lixuan Tang, Xiao Yang, Liwen He, Chaogeng Zhu, Qingshan Chen

“…Abstract Liver cancer is a highly lethal malignant tumor with a high incidence worldwide. …”
Get full text

«SAVING» A TWO-STAGE LIVER RESECTION BY THE ALPPS TYPE by D. V. Sidorov, M. V. Lozhkin, L. O. Petrov, A. G. Isaeva

Subjects: Get full text

Liver Protective Effect of Fenofibrate in NASH/NAFLD Animal Models by Ali Mahmoudi, Seyed Adel Moallem, Thomas P. Johnston, Amirhossein Sahebkar

“…Nonalcoholic fatty liver disease (NAFLD) is initiated by excessive fat buildup in the liver, affecting around 35% of the world population. …”
Get full text

Primary liver lymphoma: review of the literature and clinical case presentation by A. K. Smolyaninova, A. V. Gubkin, Ye. Ye. Zvonkov, Yu. A. Kucheryavy

“…To demonstrate the rare case of extranodal lymphoma with primary extensive liver involvement which caused difficulties at diagnosis verification. …”
Get full text

The Prognosis of Traumatic Small Bowel Injury Accompanied by Liver Injury by Yu Seong Noh, Sung Won Jung, Tae Gil Heo, Pyong Wha Choi, Jae Il Kim, Heung Man Jun, Yong Chan Shin, Sung Min Jung, Eun Hae Um

Subjects: Get full text

Factors That Could Impact on Liver Fibrosis Staging by Transient Elastography by Hugo Perazzo, Valdilea G. Veloso, Beatriz Grinsztejn, Chris Hyde, Rodolfo Castro

“…Transient elastography (TE) based on liver stiffness measurement (LSM) is one of the most validated noninvasive methods for liver fibrosis staging in patients with chronic liver diseases. …”
Get full text